research A(1-7) reduces pathologies associated with SLE in MRL-lpr mice
In this study, daily treatment with angiotensin (1-7) significantly reduced disease severity in a mouse model of Systemic Lupus Erythematosus, suggesting potential for Mas agonists in future therapies.




